This was discussed at a meeting chaired by the Prime Minister's Principal Secretary, TKA Nair, on January 12 with the Indian Bank Association, industry bodies and human resource development ministry officials.
The commerce ministry and industry bodies are in favour of FDI in the education sector. However, the HRD ministry is opposed to it.
The Mashelkar panel's recommendation to consider all modifications and variants of new chemical entities (NCEs) as patentable has invited criticism from sections of Indian pharmaceutical industry and public interest organisations
The domestic pharmaceutical industry and non-government organisations are up in arms against the first ever Indo-US tie-up on intellectual property rights
Britain's Chancellor of the Exchequer Gordon Brown will begin a three-day visit to India from January 17. Brown's visit to India assumes significance considering that this is his first ever visit to India.
Under the banner of the CII, domestic drug majors have approached Cabinet Secretary BK Chaturvedi for being allowed to present their views on the new pharmaceutical policy, scheduled to be discussed by the Union Cabinet on Thursday.
The corporate healthcare segment may replicate the success of the Indian IT sector, say experts.
The demand for chartered accountants in the corporate world has shot up with stringent income tax laws, which require compulsory maintenance of accounts by specified categories of taxpayers.
Panacea Biotec is planning to launch its organ transplantation drugs to Latin American and South East Asian markets.
Dabur Pharma, a leading player in the domestic oncology segment, is busy finalising its marketing strategies for EU, the US and Australia.
The new pharma policy proposed by Chemicals Minister Ram Vilas Paswan is likely to call for a central mechanism to oversee research and development projects in the country.
It aims at slashing the average market prices from 10 to 30 per cent for low-end brands and from 30 to 60 per cent for high-end ones.
Apart from Roche's hepatitis medicine Pegasys, which received a patent in March 2005, there have been no major announcements on grant of product patents.
Pharma Link, a joint venture of leading pharmaceutical support service provider Interpharma Asia-Pacific
Eli Lily, Sanofi Aventis, Bristol Myers approach chemicals ministry.
The Confederation of Indian Industry is expanding its presence abroad in line with India Inc's rising global aspirations.
After doctors and the armed forces, it is now the turn of chartered accountants to start their names with an honorific.
Pharma companies' hope to have several of their house hold remedy brands like Crocin made available through grocery shops across the country may not materialise.
All India Organisation of Chemists and Druggists, the apex body of over 500,000 chemists that manage the bulk of the Rs 50,000 crore
Your visit to the neighbourhood beauty parlour, dry cleaner or a cyber cafe may become cheaper in the next financial year.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances